Home › Peptides A to Z › Vitamin D, K2, Magnesium and ZincWhat is Vitamin D, K2, Magnesium and Zinc? Magnesium is described as required for AMPK to function.
Vitamin D, K2, Magnesium and Zinc in the library · · Human Trials · What are peptides?
57 registered trials · 96 indexed papers · 2331 human / 968 animal studies
From the PeptideWhiz library entry. "As described" sections summarize claims made in the sources; they are not PeptideWhiz endorsements.
What the Notes Say Educational notes on Vitamin D, K2, Magnesium and Zinc, restating how it is described in research notes. Not guidance for any person.
Magnesium is described as required for AMPK to function. The heart is described as depending on precise potassium and magnesium balance for electrical function. Zinc is described as a cofactor for the enzymes that make growth hormone. Vitamin D3 and K2 are discussed together so that calcium does not end up in the arteries. Magnesium is characterized as a natural NMDA receptor antagonist. Registered human trials (57) Peer-reviewed studies (96) Paper Authors Journal Year Type Longitudinal Height Growth Patterns Among Children Receiving Menaquinone-7 Supplementation Nguyen ND et al. Nutrients 2026 Observational Study Two Years of Menaquinone-7 Supplementation and Coronary Artery Calcification: A Randomized Clinical Trial Vossen LM et al. JAMA cardiology 2026 Randomized Controlled Trial The Effects of Vitamin K2 on Recovery from Muscle-Damaging Resistance Exercise in Young and Older Adults: The TAKEOVER Randomized Controlled Trial Lithgow H et al. Medicine and science in sports and exercise 2026 Randomized Controlled Trial Non-Fat Fermented Milk Enhanced the Bioavailability of Fat-Soluble Vitamins in Humans: A Crossover Study Morifuji M et al. Journal of nutritional science and vitaminology 2026 Randomized Controlled Trial Effects of vitamin K2 and D3 supplementation on epicardial adipose tissue and systemic inflammation: A substudy of the AVADEC trial Hasific S et al. Atherosclerosis 2025 Randomized Controlled Trial Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women de Vries F et al. Nutrients 2025 Randomized Controlled Trial Efficacy of Recombinant Human Parathyroid Hormone 1-34 and Vitamin K2 Combination Therapy in Postmenopausal Osteoporosis Zhang Z et al. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2025 Randomized Controlled Trial Vitamin K2 in Managing Nocturnal Leg Cramps: A Randomized Clinical Trial Tan J et al. JAMA internal medicine 2024 Randomized Controlled Trial No Detectable Coagulation Activation After Vitamin K (MK-7) Supplementation in Patients on Dialysis With Functional Vitamin K Deficiency: A One-Year Randomized, Placebo-Controlled Study Bladbjerg EM et al. Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2024 Randomized Controlled Trial The effect of six-month oral vitamin K supplementation on calcification propensity time in individuals with type 2 diabetes mellitus: A post hoc analysis of a randomized, double-blind, placebo-controlled trial Meer R et al. Atherosclerosis 2024 Randomized Controlled Trial Effect of Menaquinone-7 Supplementation on Arterial Stiffness in Chronic Hemodialysis Patients: A Multicenter Randomized Controlled Trial Naiyarakseree N et al. Nutrients 2023 Randomized Controlled Trial Study protocol of the InterVitaminK trial: a Danish population-based randomised double-blinded placebo-controlled trial of the effects of vitamin K (menaquinone-7) supplementation on cardiovascular, metabolic and bone health Kampmann FB et al. BMJ open 2023 Clinical Study The study of bioavailability and endogenous circadian rhythm of menaquinone-7, a form of vitamin K(2,) in healthy subjects Du F et al. The British journal of nutrition 2023 Randomized Controlled Trial Protocol for a randomised controlled trial to investigate the effects of vitamin K2 on recovery from muscle-damaging resistance exercise in young and older adults-the TAKEOVER study Lithgow H et al. Trials 2022 Clinical Study Effect of vitamin K2 administration on depression status in patients with polycystic ovary syndrome: a randomized clinical trial Tarkesh F et al. BMC women's health 2022 Randomized Controlled Trial Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial Diederichsen ACP et al. Circulation 2022 Randomized Controlled Trial The effect of menaquinone-7 supplementation on dp-ucMGP, PIVKAII, inflammatory markers, and body composition in type 2 diabetes patients: a randomized clinical trial Karamzad N et al. Nutrition & diabetes 2022 Randomized Controlled Trial Vitamin K2 as a potential therapeutic candidate for the prevention of muscle cramps in hemodialysis patients: A prospective multicenter, randomized, controlled, crossover pilot trial Xu D et al. Nutrition (Burbank, Los Angeles County, Calif.) 2022 Randomized Controlled Trial Concurrent Treatment with Vitamin K2 and D3 on Spine Fusion in Patients with Osteoporosis-Associated Lumbar Degenerative Disorders Zhang W et al. Spine 2022 Controlled Clinical Trial The impact of vitamin K2 and native vitamin D supplementation on vascular calcification in pediatric patients on regular hemodialysis. A randomized controlled trial El Borolossy R et al. European journal of clinical nutrition 2022 Randomized Controlled Trial Fat-Soluble Vitamin Supplementation Using Liposomes, Cyclodextrins, or Medium-Chain Triglycerides in Cystic Fibrosis: A Randomized Controlled Trial Nowak JK et al. Nutrients 2021 Randomized Controlled Trial Effects of vitamin K2 supplementation on atherogenic status of individuals with type 2 diabetes: a randomized controlled trial Rahimi Sakak F et al. BMC complementary medicine and therapies 2021 Randomized Controlled Trial Safety and Efficacy of Vitamin K Antagonists versus Rivaroxaban in Hemodialysis Patients with Atrial Fibrillation: A Multicenter Randomized Controlled Trial De Vriese AS et al. Journal of the American Society of Nephrology : JASN 2021 Randomized Controlled Trial Vitamin K2 (menaquinone-7) increases plasma adiponectin but does not affect insulin sensitivity in postmenopausal women: a randomized controlled trial Rønn SH et al. European journal of clinical nutrition 2021 Randomized Controlled Trial Effect of vitamin K2 and vitamin D3 on bone mineral density in children with acute lymphoblastic leukemia: a prospective cohort study Solmaz I et al. Journal of pediatric endocrinology & metabolism : JPEM 2021 Randomized Controlled Trial Effect of Low-Dose Vitamin K2 Supplementation on Bone Mineral Density in Middle-Aged and Elderly Chinese: A Randomized Controlled Study Zhang Y et al. Calcified tissue international 2020 Randomized Controlled Trial Vitamin K2 Status and Arterial Stiffness Among Untreated Migraine Patients: A Case-Control Study Mansour AG et al. Headache 2020 Observational Study Multicenter Randomized Controlled Trial of Vitamin K Antagonist Replacement by Rivaroxaban with or without Vitamin K2 in Hemodialysis Patients with Atrial Fibrillation: the Valkyrie Study De Vriese AS et al. Journal of the American Society of Nephrology : JASN 2020 Randomized Controlled Trial The effect of vitamin K2 supplementation on vascular calcification in haemodialysis patients: a 1-year follow-up randomized trial Oikonomaki T et al. International urology and nephrology 2019 Randomized Controlled Trial The effect of menaquinone-7 supplementation on vascular calcification in patients with diabetes: a randomized, double-blind, placebo-controlled trial Zwakenberg SR et al. The American journal of clinical nutrition 2019 Randomized Controlled Trial
More cited research Interaction between vitamin D insufficiency and periodontitis, GCF vitamin D and LL-37 levels in well-controlled diabetes patients with periodontitis (2026, human observational)Serological biomarker models composed of luteinizing hormone, kisspeptin, vitamin D and estradiol, and their clinical test value in girls (2026, human observational)The Role of Vitamin D in Modulating the Innate Immune Response in Children with Vesicoureteral Reflux (2026, human observational)Vitamin D receptor BsmI haplotype BB confers lower 25(OH)D levels during tuberculosis: a pilot cross-sectional study (2026, human observational)Menaquinone-4 attenuates ferroptosis by upregulating DHODH through activation of SIRT1 after subarachnoid hemorrhage (2024, animal)The effect of coadministration of vitamin D and tramadol on serum kisspeptin, testosterone, oxidative stress levels and testicular histology in Wistar rats: a p (2024, animal)Vitamin K2 ameliorates osteoarthritis by suppressing ferroptosis and extracellular matrix degradation through activation GPX4's dual functions (2024, animal)Ameliorating Effects of Vitamin K2 on Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice (2023, animal)Conditions researched Anemia Atherosclerosis, cardiovascular disease & high blood pressure Fatigue & low energy (incl. midlife) Fight-or-flight and nervous system overdrive Skin sensitivity and body aches on GLP-1 medicines Gum disease (periodontal) & oral health Heart repair: after heart attack, heart failure & enlarged heart Herpes (HSV) and cold sores High cholesterol and statins Hyperparathyroidism Insulin resistance, prediabetes & type 2 diabetes Lipedema Low testosterone (without or alongside TRT) Male fertility and sperm Migraine Muscle gain, sarcopenia & building muscle after 40 PMDD (premenstrual dysphoric disorder) Raynaud's Rheumatoid arthritis Sexual function & libido (women and men) Skin, hair loss, wounds & mast-cell/histamine reactivity Sleep apnea (obstructive) Sleep problems (incl. insomnia on peptides) Swollen feet and ankles Thyroid problems Anti-aging & longevity Chronic and systemic inflammation Concussion, traumatic brain injury & stroke recovery Fat loss, obesity & body recomposition Immune system (general) Kidney protection (CKD, diabetic kidney, lupus kidney) Loose skin Lung health, asthma & COPD Osteoporosis and bone density PCOS Pregnancy and breastfeeding: safety notes SIBO Thick blood and blood clots Related compounds FAQ What is Vitamin D, K2, Magnesium and Zinc? Magnesium is described as required for AMPK to function.
How many registered human trials study Vitamin D, K2, Magnesium and Zinc? The PeptideWhiz trial index lists 57 registered trials for Vitamin D, K2, Magnesium and Zinc, the most recent from 2026.
How much published research exists on Vitamin D, K2, Magnesium and Zinc? The PeptideWhiz paper index links 96 PubMed papers to Vitamin D, K2, Magnesium and Zinc; by study type, 2331 human and 968 animal studies.
Which conditions is Vitamin D, K2, Magnesium and Zinc researched for? Anemia, Atherosclerosis, cardiovascular disease & high blood pressure, Fatigue & low energy (incl. midlife), Fight-or-flight and nervous system overdrive, Skin sensitivity and body aches on GLP-1 medicines, Gum disease (periodontal) & oral health, Heart repair: after heart attack, heart failure & enlarged heart, Herpes (HSV) and cold sores, High cholesterol and statins, Hyperparathyroidism, Insulin resistance, prediabetes & type 2 diabetes, Lipedema, Low testosterone (without or alongside TRT), Male fertility and sperm, Migraine, Muscle gain, sarcopenia & building muscle after 40, PMDD (premenstrual dysphoric disorder), Raynaud's, Rheumatoid arthritis, Sexual function & libido (women and men), Skin, hair loss, wounds & mast-cell/histamine reactivity, Sleep apnea (obstructive), Sleep problems (incl. insomnia on peptides), Swollen feet and ankles, Thyroid problems, Anti-aging & longevity, Chronic and systemic inflammation, Concussion, traumatic brain injury & stroke recovery, Fat loss, obesity & body recomposition, Immune system (general), Kidney protection (CKD, diabetic kidney, lupus kidney), Loose skin, Lung health, asthma & COPD, Osteoporosis and bone density, PCOS, Pregnancy and breastfeeding: safety notes, SIBO, Thick blood and blood clots.
Research and education only. Not medical advice. No dosing guidance. Data: ClinicalTrials.gov registry and PubMed via the PeptideWhiz index (204,289 studies).